Viyash Scientific Limited (NSE:SEQUENT) — Market Cap & Net Worth

$529.07 Million USD · Rs48.92 Billion INR · Rank #12000

Market Cap & Net Worth: Viyash Scientific Limited (SEQUENT)

Viyash Scientific Limited (NSE:SEQUENT) has a market capitalization of $529.07 Million (Rs48.92 Billion) as of October 11, 2026. Listed on the NSE stock exchange, this India-based company holds position #12000 globally and #593 in its home market, demonstrating a 0.60% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Viyash Scientific Limited's stock price Rs193.72 by its total outstanding shares 252537098 (252.54 Million).

Viyash Scientific Limited Market Cap History: 2016 to 2026

Viyash Scientific Limited's market capitalization history from 2016 to 2026. Data shows growth from $298.04 Million to $529.07 Million (0.84% CAGR). Check SEQUENT live share price for real-time trading data and today's change.

Index Memberships

Viyash Scientific Limited is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY MICROCAP 250 NIFTYMICROCAP250	$149.82 Billion	0.35%	#98 of 250
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.03 Trillion	0.02%	#452 of 750

Weight: Viyash Scientific Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Viyash Scientific Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Viyash Scientific Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Viyash Scientific Limited (SEQUENT) cash conversion ratio for how efficiently the company converts equity into cash flow.

Latest Price to Sales (P/S) Ratio

0.04x

Viyash Scientific Limited's market cap is 0.04 times its annual revenue

Industry average: 0.62x Lower than industry average

Latest Price to Earnings (P/E) Ratio

2.60x

Viyash Scientific Limited's market cap is 2.60 times its annual earnings

Industry average: 14.18x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$298.04 Million	$6.01 Billion	-$184.69 Million	0.05x	N/A
2017	$265.22 Million	$6.78 Billion	-$138.24 Million	0.04x	N/A
2018	$184.10 Million	$8.42 Billion	$4.22 Billion	0.02x	0.04x
2019	$192.68 Million	$10.22 Billion	$486.60 Million	0.02x	0.40x
2020	$462.05 Million	$11.61 Billion	$699.05 Million	0.04x	0.66x
2021	$439.43 Million	$13.52 Billion	$954.42 Million	0.03x	0.46x
2022	$239.24 Million	$14.10 Billion	$409.55 Million	0.02x	0.58x
2023	$310.66 Million	$14.18 Billion	-$1.21 Billion	0.02x	N/A
2024	$480.29 Million	$13.66 Billion	-$358.69 Million	0.04x	N/A
2025	$569.54 Million	$15.51 Billion	$218.80 Million	0.04x	2.60x

Competitor Companies of SEQUENT by Market Capitalization

Companies near Viyash Scientific Limited in the global market cap rankings as of October 11, 2026. See Viyash Scientific Limited net asset quality index to understand what proportion of total assets are financed by equity.

Key companies related to Viyash Scientific Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #585 globally with a market cap of $46.39 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #628 globally with a market cap of $43.73 Billion USD ( CN¥298.86 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #630 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#524	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#585	GALDERMA GROUP AG	NYSE:GALDY	$46.39 Billion	$39.79
#628	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$43.73 Billion	CN¥46.85
#630	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€16.30

Viyash Scientific Limited Historical Marketcap From 2016 to 2026

Between 2016 and today, Viyash Scientific Limited's market cap moved from $298.04 Million to $ 529.07 Million, with a yearly change of 0.84%.

Year	Market Cap	Change (%)
2026	Rs529.07 Million	-7.11%
2025	Rs569.54 Million	+18.58%
2024	Rs480.29 Million	+54.60%
2023	Rs310.66 Million	+29.85%
2022	Rs239.24 Million	-45.56%
2021	Rs439.43 Million	-4.89%
2020	Rs462.05 Million	+139.80%
2019	Rs192.68 Million	+4.66%
2018	Rs184.10 Million	-30.58%
2017	Rs265.22 Million	-11.01%
2016	Rs298.04 Million	--

End of Day Market Cap According to Different Sources

On Oct 10th, 2026 the market cap of Viyash Scientific Limited was reported to be:

Source	Market Cap
Yahoo Finance	$529.07 Million USD
MoneyControl	$529.07 Million USD
MarketWatch	$529.07 Million USD
marketcap.company	$529.07 Million USD
Reuters	$529.07 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Viyash Scientific Limited

NSE:SEQUENT India Drug Manufacturers - Specialty & Generic

Market Cap

$529.07 Million

Rs48.92 Billion INR

Market Cap Rank

#12000 Global

#593 in India

Share Price

Rs193.72

Change (1 day)

-3.70%

52-Week Range

Rs190.05 - Rs252.00

All Time High

Rs322.89